Estcourt, Lise J. http://orcid.org/0000-0003-4309-9162
,
McQuilten, Zoe
Powter, Gillian
Dyer, Claire
Curnow, Eleanor
Wood, Erica M.
Stanworth, Simon J.
Funding for this research was provided by:
NHS Blood and Transplant
Article History
Received: 11 April 2019
Accepted: 19 August 2019
First Online: 15 October 2019
Ethics approval and consent to participate
: This trial complies with the Declaration of Helsinki (2013) [CitationRef removed]. It will be conducted in compliance with the approved protocol, the principles of Good Clinical Practice, the UK Data Protection Act and the National Health Service (NHS) Research Governance Framework for Health and Social Care (RGF) and the Australian NHMRC National Statement on Ethical Conduct in Research Involving Humans (March 2007). Informed consent will be obtained from all study participants prior to enrolment.The trial was approved by the South-Central Oxford C Research Ethics Committee on 5 November 2014 (REC reference number: 14/SC/1290), which provided both central and local ethical approval. The trial is registered with the Medicines and Healthcare products Regulatory Agency (MHRA) (EudraCT number 2014–001513-35). This trial was approved by NIHR Clinical Research Network and is therefore part of the Haematology CSG and Haematology Oncology research network portfolio.
: Not applicable.
: The authors declare that they have no competing interests.